Godavari

No time anna

Ante sundaram headache movie. simply waste of time

Beast movie in netlflix

Fever ochina emi parledu ani schools ki pampistara father . Padipothe cycle chuskuntara asala nachaledu ah scenes . Ilage chesthe Baga chadavtara emina convincing ga unda anduke avi ekkaledu valla amma sentiment scene baganeundi kani valla nana Ala enduku behave chesaro convincing ledu

Don edo vundi.emotion peddga click avvaledu. Valla nana kodukuni Ala enduku treat cheyalo asala convincing ledu edo tisesaru. S j surya character

Janalaki ela ekkutado tarvatha Mata mana opinion manaki undali ga vallaki ela untado ohinchukuni enduku chepadam

Dj tillu sodi comedy oka song tho Ala mouth publicity lagesara 🤯 Jathirathnalu range no way

Except last 20 mins Pushpa

A Anukoni athidi aha nice

Trump Vs Biden first debate in September 29.. Next week market meda effect

https://www.telegraph.co.uk/news/2020/09/26/us-election-debates-schedule-date-when-donald-trump-joe-biden-time/

5 things to know about KKR-Reliance Retail deal https://www.moneycontrol.com/news/business/5-things-to-know-about-kkr-reliance-retail-deal-5873521.html Download moneycontrol app: http://m.moneycontrol.com/mom

Repu emina perigipotada dini Valla 🤔

Aurobindo Pharma & Council Of Scientific & Industrial Research collaborate to develop COVID-19 vaccine

https://www.livemint.com/news/india/ril-arm-acquires-majority-stake-in-online-pharmacy-netmeds-for-rs-620-crore-11597775715355.html

AGR CASE LO JIO kuda ipudu involve Monday reliance padachaa..padithe market kuda padatadi ga

Reliance 3000 aypotada year loneee Long term ki uncheskovadam better emo konesi

Dow Jones +250

😲

12000 kuda touch aypotada e ooplo August lo

Corona taggithe gold malli 40k to 45k levels ki ostada

Cases emo perugutanayiii malli lockdown lu nifty emo near to 11000 asala logic ardamkavatledu emina crash ostada e week

Reliance Google deal confirm ayyanaa antha ala padatamu entoo 🤯

https://m.hindustantimes.com/world-news/moderna-phase-1-results-show-covid-19-vaccine-safe-induces-immune-response/story-vEMNOUskkkCfSeX0yBRViI.html